Document 0502 DOCN M9460502 TI Human granulocyte colony-stimulating factor (G-CSF), the premier granulopoietin: biology, clinical utility, and receptor structure and function. DT 9404 AU Tkatch LS; Tweardy DJ; Department of Medicine, University of Pittsburgh School of; Medicine, PA 15213. SO Lymphokine Cytokine Res. 1993 Dec;12(6):477-88. Unique Identifier : AIDSLINE MED/94169273 AB In summary, both G-CSF and GM-CSF have been identified, cloned, and produced for pharmacologic use in humans. While both G-CSF and GM-CSF have had significant impact in the treatment of neutropenic states, G-CSF appears to be more advantageous than GM-CSF in overall efficacy and paucity of side effects. Much has been discovered about the structure of the G-CSF receptor but further work is necessary to determine its mechanism of signal transduction. As our understanding of G-CSF signaling advances, the therapeutic impact of our knowledge about G-CSF biology will evolve from the current focus on enhancing its effects in hematologic and oncologic illnesses to decreasing its effects in inflammatory conditions where overexhuberant neutrophil infiltration and activation cause disease. DE Acquired Immunodeficiency Syndrome/THERAPY Amino Acid Sequence Animal Bone Marrow Transplantation Granulocyte Colony-Stimulating Factor/*PHYSIOLOGY/*THERAPEUTIC USE Granulocyte-Macrophage Colony-Stimulating Factor/BIOSYNTHESIS Granulocytes/METABOLISM/*PHYSIOLOGY Hematopoiesis/*PHYSIOLOGY Human Leukemia/THERAPY Molecular Sequence Data Neoplasms/*THERAPY Neutropenia/*THERAPY Preleukemia/THERAPY Receptors, Granulocyte Colony-Stimulating Factor/BIOSYNTHESIS/ CHEMISTRY/*METABOLISM Signal Transduction Stem Cells/TRANSPLANTATION Support, Non-U.S. Gov't Support, U.S. Gov't, P.H.S. JOURNAL ARTICLE REVIEW REVIEW, ACADEMIC SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).